Nandaki Keshavan

6PUBLICATIONS
13CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyAutonomic nervous systemMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 25, 2024
Interferon Stimulated Gene Expression Is a Biomarker for Primary Mitochondrial Disease.

Nandaki Keshavan, Lana Mhaldien, Kimberly Gilmour

|Jan 03, 2024
Gene therapy for mitochondrial disorders.

Nandaki Keshavan, Michal Minczuk, Carlo Viscomi

|Mar 14, 2022
Clinical status, biochemical profile and management of a single cohort of patients with arginase deficiency.

Nandaki Keshavan, Michelle Wood, Lucy M Alderson

|Jul 04, 2020
Moving towards clinical trials for mitochondrial diseases.

Robert D S Pitceathly, Nandaki Keshavan, Joyeeta Rahman

|Nov 28, 2019
Cardiac valve involvement in <i>ADAR</i>-related type I interferonopathy.

Yanick Crow, Nandaki Keshavan, Jacques Patrick Barbet

|Aug 30, 2019
The natural history of infantile mitochondrial DNA depletion syndrome due to RRM2B deficiency.

Nandaki Keshavan, Jose Abdenur, Glenn Anderson

Pageof 1